Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Yazarlar (13)
Mustafa Argun
Sağlık Bilimleri Üniversitesi, Türkiye
Sağlık Bilimleri Üniversitesi, Türkiye
Kazım Üzüm
Türkiye
Türkiye
Mehmet Fatih Sönmez
Türkiye
Türkiye
Abdullah Özyurt Toros Üniversitesi, Türkiye
Derya Karabulut Erciyes Üniversitesi, Türkiye
Zeynep Soyer Sarıca
Türkiye
Türkiye
Dr. Öğr. Üyesi Kübra Tuğçe KALKAN Kırşehir Ahi Evran Üniversitesi, Türkiye
Sunay Ünalmış
Türkiye
Türkiye
Özge Pamukçu Türkiye
Ali Baykan Türkiye
Figen Narin Türkiye
Ferhan Elmalı Türkiye
Nazmi Narin
Türkiye
Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | ANATOLIAN JOURNAL OF CARDIOLOGY | ||
| Dergi ISSN | 2149-2263 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 04-2016 |
| Cilt / Sayı / Sayfa | 16 / 4 / 234–241 | DOI | 10.5152/akd.2015.6185 |
| Makale Linki | http://dx.doi.org/10.5152/akd.2015.6185 | ||
| Özet |
| Objective The clinical use of doxorubicin, which is a strong antineoplastic agent, is limited due to its cardiotoxic side effects. Metformin is a drug with antihyperglycemic effects, and it has been shown to have a cardioprotective effect on left ventricular function in experimental animal models of myocardial ischemia. The present study investigated the cardioprotective effect of metformin in rats with doxorubicin cardiotoxicity. Methods Wistar albino rats were used in the study. Forty male, 10-week-old Wistar albino rats were randomly divided four groups. The control group rats were intraperitoneally administered saline solution twice a week, four doses in total. The doxorubicin group rats received doxorubicin (4 mg/kg, twice a week, cumulative dose: 16 mg/kg) intraperitoneally. The metformin group rats received metformin (250 mg/kg/day, every day for 14 days) via gavage. The doxorubicin+ metformin group rats received doxorubicin and metformin at the same dose. Left ventricular functions were evaluated by using M-mode echocardiography one day after the last dose of doxorubicin. Heart tissue samples were histopathologically examined. Cardiomyocyte apoptosis was detected using in situ terminal deoxynucleotide transferase assay (TUNEL). Serum brain natriuretic peptide and C-type natriuretic peptide levels were measured. Catalase, superoxide dismutase, glutathione peroxidase, and tumor necrosis factor alpha levels were analyzed in the heart tissue. The assumptions of equality of variances and normal distribution were checked for all variables (Shapiro-Wilk test and QQ graphics). To identify intergroup differences, one-way variant analysis or … |
| Anahtar Kelimeler |
| doxorubicin | cardiotoxicity | metformin | antioxidant | echocardiography |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Web of Science | 69 |